Subscribe to our Newsletters !!
Few developments in science and technology have be
The pharmaceutical sector is experiencing revoluti
The recent rabies death of an 11 year old Canadian
Alembic Pharmaceutica
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Mi
Roche drug Hemlibra has a good chance to become the first choice of treatment for the patients who are suffering from Hemopilia.Basically, Hemlibra is a humanized monoclonal antibody drug for the treatment of haemophilia which is given through an injection, it was observed that it reduces the bleed dramatically in hemphilia tests.
At the world Federation of Hemophilia’s world congress in Scotland,Roche’s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 & HEAVEN-4.
At the world Federation of Hemophilia’s world congress in Scotland,Roche’s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 & HEAVEN-4..
It was reported that Hemlibra was able to cut down 96% of the bleeds in Hemophilia. Some comparisons were observed between a patient who didn’t received preventive treatment whereas a patient who received the preventive treatment in the form of clotting factors it reduces them by 68%.
The firm will submit the new data to regulators in the U.S. and Europe for approval.
